Method of producing vaccines from protein signal oligopeptides

Details Method of producing vaccines from protein signal oligopeptides Method of producing vaccines from protein signal oligopeptides

2007-11-27

2007-11-27

Parkin, Jeffrey (Department: 1648)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

Reexamination Certificate

active

10930300

ABSTRACT:
The description discloses a method of producing therapeutic peptides as vaccines in the prevention of human diseases that are caused by one or more proteins. The method comprises identifying the protein responsible for causing the human disease; identifying one or more signal oligopeptide sequences within the structure of the disease causing protein, the one or more signal oligopeptides representing the amino acid sequence of maximum hydrophilicity; and synthesizing one or more vaccine oligopeptides, the vaccine oligopeptides having amino acid sequences corresponding to the amino acid sequences of the signal oligopeptides of maximum hydrophilicity.

REFERENCES:
patent: 4554101 (1985-11-01), Hopp
patent: WO 89/05823 (1989-06-01), None
patent: WO 89/10405 (1989-11-01), None
Rath, “Cationic-Anionic and Anionic-Cationic Oligopeptides in Apoprotein a and other proteins as Modulators of Protein Action . . . ,” Journal of Applied Nutrition (1992) vol. 44, Nos. 3 and 4.
Hopp, TP and Woods, KR, Proc. Natl. Acad. Sci. USA (1981) 78:3824-3828.
Boger, Proceedings of the 1988 Miami Bio/Technology Winter Symposium. 10. Oxford and Washington. IRL Press.
Riffkin et al., “A single amino-acid change between the antigenically different extracellular serine proteases V2 and B2 from Dichelobacter nodosus,” Gene, vol. 167 (1995) pp. 279-283.
Abaza et al., “Effects of amino acid substitutions outside an antigenic site on protein binding to monoclonal antibodies of predetermined specificity obtained by peptide immunization,” Journal of Protein Chemistry (1992) vol. 11, No. 5, pp. 433-444.
Cruse et al.,Illustrated Dictionary of Immunolgy(Boca Raton, FL, CRC Press, Inc., 1995) p. 309 QR180.4.C78.
Paul,Fundamental Immunology(Philadelphia & New York, Lippincott-Raven Publishers, 1993) pp. 250 and 1311-1312 QR181.F84.
Cohen et al., “Pronounced acute immunosuppression in vivo mediated by HIV Tat challenge,” Proceedings of the National Academy of Sciences of the United States of America (Sep. 14, 1999) vol. 96, Issue 19, pp. 10842-10847.
Watanabe et al., “Molecular Cloning of a Novel Ca (2+)-Binding protein (calmegin) Specifically Expressed During Male Meiotic Germ Cell Development,” Journal of Biological Chemistry (Mar. 11, 1994) vol. 269, No. 10, pp. 7744-7749.
Hogh et al., “Glutamate Rich Plasmodium Falciparum Antigen (GLURP),” Parassitologia (Jul. 1993) vol. 35, Suppl. 47-50.

Affiliated with

Also associated with

Rating

Method of producing vaccines from protein signal oligopeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of producing vaccines from protein signal oligopeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of producing vaccines from protein signal oligopeptides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3851922